Mediobanca analyst Marco Vitale maintained a Buy rating on Gefran SPA today and set a price target of €12.00.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Marco Vitale has given his Buy rating due to a combination of factors, primarily focusing on Gefran SPA’s resilient performance amidst a challenging macroeconomic environment. The company has shown a steady mid-single-digit growth trajectory, supported by positive trends in the US and Asia, which are expected to counterbalance the softer demand from European markets. Despite some margin compression due to increased operational costs, the management remains optimistic about continued growth in the latter half of the year, driven by improving intake momentum.
Furthermore, Marco Vitale highlights the potential for profitability improvement through operating leverage as volumes recover. The focus on research and development, efficiencies, and integration of mergers and acquisitions is expected to bolster the company’s performance. The target price of €12 per share remains unchanged, reflecting confidence in Gefran’s ability to achieve its organic growth and profitability forecasts, even with minor adjustments to financial estimates.
According to TipRanks, Vitale is ranked #5568 out of 9859 analysts.